Selvom dette ikke er dokumenteret for Irbesartan BMS, kan der forventes en lignende effekt med angiotensin- II - receptorantagonister.
While this is not documented with Irbesartan BMS, a similar effect should be anticipated with angiotensin-II receptor antagonists.